First Time Loading...
S

Shin Nippon Biomedical Laboratories Ltd
TSE:2395

Watchlist Manager
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Watchlist
Price: 1 416 JPY -3.34% Market Closed
Updated: May 15, 2024

EV/EBITDA
Enterprise Value to EBITDA

11.3
Current
12.6
Median
17.5
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
11.3
=
Enterprise Value
64.6B
/
EBITDA
5.7B
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
10.5
2-Years Forward
EV/EBITDA
8
3-Years Forward
EV/EBITDA
5.9

See Also

Discover More